Sexual dimorphisms in zonal gene expression in mouse liver

Biochemical and Biophysical Research Communications

Volumn 436, Issue 4, 2013, Pages 730-735

  Saito, Kosuke ^a   Negishi, Masahiko ^a   James Squires, E ^a,b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Hepatic zonation; Laser capture microdissection (LCM); Sexual dimorphism

Indexed keywords

RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN F1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GLUCONEOGENESIS; LASER CAPTURE MICRODISSECTION; LIVER METABOLISM; MALE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; STEM CELL;

GH; GROWTH HORMONE; HEPATIC ZONATION; HEPATOCYTE NUCLEAR FACTOR 4 ALPHA; HNF4; LASER CAPTURE MICRODISSECTION; LASER CAPTURE MICRODISSECTION (LCM); LCM; RIN; RNA INTEGRITY NUMBER; SEXUAL DIMORPHISM; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION; STAT;

ANIMALS; FEMALE; GENE EXPRESSION PROFILING; LIVER; MALE; MICE; MICE, INBRED C3H; QUALITY CONTROL; SEX CHARACTERISTICS; TRANSCRIPTION, GENETIC;

MUS;

EID: 84880036756     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.025     Document Type: Article

References (34)

1. Jungermann K. Functional heterogeneity of periportal and perivenous hepatocytes. Enzyme 1986, 35:161-180.
2. Jungermann K., Katz N.R. Functional specialization of different hepatocyte populations. Physiol. Rev. 1989, 69:708-764.
3. Jungermann K. Metabolic zonation of liver parenchyma. Semin. Liver Dis. 1988, 8:329-341.
4. Jungermann K., Kietzmann T. Zonation of parenchymal and nonparenchymal metabolism in liver. Annu. Rev. Nutr. 1996, 16:179-203.
5. Katz N.R. Metabolic heterogeneity of hepatocytes across the liver acinus. J. Nutr. 1992, 122:843-849.
6. Torre C., Perret C., Colnot S. Transcription dynamics in a physiological process: beta-catenin signaling directs liver metabolic zonation. Int. J. Biochem. Cell Biol. 2011, 43:271-278.
7. Ahluwalia A., Clodfelter K.H., Waxman D.J. Sexual dimorphism of rat liver gene expression: regulatory role of growth hormone revealed by deoxyribonucleic acid microarray analysis. Mol. Endocrinol. 2004, 18:747-760.
8. Waxman D.J., Holloway M.G. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol. Pharmacol. 2009, 76:215-228.
9. Shapiro B.H., Agrawal A.K., Pampori N.A. Gender differences in drug metabolism regulated by growth hormone. Int. J. Biochem. Cell Biol. 1995, 27:9-20.
10. Mugford C.A., Kedderis G.L. Sex-dependent metabolism of xenobiotics. Drug Metab. Rev. 1998, 30:441-498.
11. Wauthier V., Waxman D.J. Sex-specific early growth hormone response genes in rat liver. Mol. Endocrinol. 2008, 22:1962-1974.
12. Subramanian A., Wang J., Gil G. STAT5 and NF-Y are involved in expression and growth hormone-mediated sexually dimorphic regulation of cytochrome P450 3A10/lithocholic acid 6β-hydroxylase. Nucleic Acids Res. 1998, 26:2173-2178.
13. Sueyoshi T., Yokomori N., Korach K.S., Negishi M. Developmental action of estrogen receptor-alpha feminizes the growth hormone-Stat5b pathway and expression of Cyp2a4 and Cyp2d9 genes in mouse liver. Mol. Pharmacol. 1999, 56:473-477.
14. Holloway M.G., Cui Y., Laz E.V., Hosui A., Hennighausen L., Waxman D.J. Loss of sexually dimorphic liver gene expression upon hepatocyte-specific deletion of Stat5a-Stat5b locus. Endocrinology 2007, 148:1977-1986.
15. Lahuna O., Rastegar M., Maiter D., Thissen J., Lemaigre F.P., Rousseau G.G. Involvement of STAT5 (signal transducer and activator of transcription 5) and HNF-4 (hepatocyte nuclear factor 4) in the transcriptional control of the HNF6 gene by growth hormone. Mol. Endocrinol. 2000, 14:285-294.
16. Holloway M.G., Laz E.V., Waxman D.J. Codependence of growth hormone-responsive, sexually dimorphic hepatic gene expression on signal transducer and activator of transcription 5b and hepatic nuclear factor 4α. Mol. Endocrinol. 2006, 20:647-660.
17. Yamazaki Y., Moore R., Negishi M. Nuclear receptor CAR (NR1I3) is essential for DDC-induced liver injury and oval cell proliferation in mouse liver. Lab. Invest. 2011, 91:1624-1633.
18. Saito K., Moore R., Negishi M. Nuclear receptor CAR specifically activates the two-pore K+ channel Kcnk1 gene in male mouse livers, which attenuates phenobarbital-induced hepatic hyperplasia. Toxicol. Sci. 2013, 132:151-161.
19. Coudry R.A., Meireles S.I., Stoyanova R., Cooper H.S., Carpino A., Wang X., Engstrom P.F., Clapper M.L. Successful application of microarray technology to microdissected formalin-fixed, paraffin-embedded tissue. J. Mol. Diagn. 2007, 9:70-79.
20. Braeuning I., Ittrich C., Köhle C., Hailfinger S., Bonin M., Buchmann A., Schwarz M. Differential gene expression in periportal and perivenous mouse hepatocytes. FEBS J. 2006, 273:5051-5061.
21. Gustavsson C., Yassin K., Wahlstrom E., Cheung L., Lindberg J., Brismar K., Ostenson C.G., Norstedt G., Tollet-Egnell P. Sex-different hepatic glycogen content and glucose output in rats. BMC Biochem. 2010, 11:38.
22. Harada H., Pavlick K.P., Hines I.N., Hoffman J.M., Bharwani S., Gray L., Wolf R.E., Grisham M.B. Selected contribution: effects of gender on reduced-size liver ischemia and reperfusion injury. J. Appl. Physiol. 2001, 91:2816-2822.
23. Shan Y.S., Hsieh Y.H., Sy E.D., Chiu N.T., Lin P.W. The influence of spleen size on liver regeneration after major hepatectomy in normal and early cirrhotic liver. Liver Int. 2005, 25:96-100.
24. Napoli J.L. Retinoic acid biosynthesis and metabolism. FASEB J. 1996, 10:993-1001.
25. Benhamouche S., Decaens T., Godard C., Chambrey R., Rickman D.S., Moinard C., Vasseur-Cognet M., Kuo C.J., Kahn A., Perret C., Colnot S. Apc tumor suppressor gene is the "zone-keeper" of mouse liver. Dev. Cell 2006, 10:759-770.
26. Giera S., Braeuning A., Kohle C., Bursch W., Metzger U., Buchmann A., Schwarz M. Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferase in mouse liver. Toxicol. Sci. 2010, 115:22-33.
27. Shimano H. Sterol regulatory element-binding protein family as global regulator of lipid synthetic genes in energy metabolism. Vitam. Horm. 2002, 65:167-194.
28. Eberle D., Hegarty B., Bossard P., Ferre P., Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 2004, 86:839-848.
29. Van Noorden C.J.F., Vogels I.M.C. Adaptive sex-dependent changes in the zonation of carbohydrate and lipid metabolism in rat liver lobules after partial hepatectomy. Hepatology 1994, 20:714-724.
30. Le Douarin B., Zechel C., Garnier J.M., Lutz Y., Tora L., Pierrat P., Heery D., Gronemeyer H., Chambon P., Losson R. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 1995, 14:2020-2033.
31. Teyssier C., Qu C.Y., Khetchoumian K., Losson R., Stallcup M.R. Transcriptional intermediary factor 1 alpha mediates physical interaction and functional synergy between the coactivator-associated arginine methyltransferase 1 and glucocorticoid receptor-interacting protein 1 nuclear receptor coactivators. Mol. Endocrinol. 2006, 20:1276-1286.
32. Khetchoumian K., Teletin M., Tisserand J., Mark M., Herquel B., Ignat M., Zucman-Rossi J., Cammas F., Lerouge T., Thibault C., Metzger D., Chambon P., Losson R. Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha. Nat. Genet. 2007, 39:1500-1506.
33. Poole T.M., Drinkwater N.R. Strain dependent effects of sex hormones on hepatocarcinogenesis in mice. Carcinogenesis 1996, 17:191-196.
34. Naugler W.E., Sakurai T., Kim S., Maeda S., Kim K., Elsharkawy A.M., Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007, 317:121-124.